Diagnosis, pathophysiology, and management of cluster headache

Lancet Neurol. 2018 Jan;17(1):75-83. doi: 10.1016/S1474-4422(17)30405-2. Epub 2017 Nov 23.


Cluster headache is a trigeminal autonomic cephalalgia characterised by extremely painful, strictly unilateral, short-lasting headache attacks accompanied by ipsilateral autonomic symptoms or the sense of restlessness and agitation, or both. The severity of the disorder has major effects on the patient's quality of life and, in some cases, might lead to suicidal ideation. Cluster headache is now thought to involve a synchronised abnormal activity in the hypothalamus, the trigeminovascular system, and the autonomic nervous system. The hypothalamus appears to play a fundamental role in the generation of a permissive state that allows the initiation of an episode, whereas the attacks are likely to require the involvement of the peripheral nervous system. Triptans are the most effective drugs to treat an acute cluster headache attack. Monoclonal antibodies against calcitonin gene-related peptide, a crucial neurotransmitter of the trigeminal system, are under investigation for the preventive treatment of cluster headache. These studies will increase our understanding of the disorder and perhaps reveal other therapeutic targets.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Local / administration & dosage
  • Anesthetics, Local / pharmacology*
  • Cluster Headache / diagnosis
  • Cluster Headache / drug therapy*
  • Cluster Headache / etiology*
  • Cluster Headache / physiopathology*
  • Humans
  • Lidocaine / administration & dosage
  • Lidocaine / pharmacology*
  • Oxygen / administration & dosage
  • Oxygen / pharmacology*
  • Tryptamines / administration & dosage
  • Tryptamines / pharmacology*


  • Anesthetics, Local
  • Tryptamines
  • Lidocaine
  • Oxygen